The drug regulator said in case of emergency, they are would granting import license without registration certificate subject to approval of government.
In an effort to provide quick access to vaccines and drugs to treat COVID-19, the Drug Controller General of India (DCGI) has announced several measures including expediting reviews and approvals for drugs and vaccines already approved in other countries. The Indian drug regulator will also grant speedy permissions for clinical trials, waiver of data requirement for animal studies and approval of manufacturing licenses within seven days.
The drug regulator said, in case of emergency ...
Read the full text moneycontrol